VytronUS, Inc. was formed in 2006 to harness the imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias, starting with atrial fibrillation. We recognize that today's marketed technologies have limitations. Only a new energy source, such as collimated ultrasound, can shift the treatment paradigm to more predictable outcomes. We strive to make a complicated procedure simple. Ease of use guides every aspect of our design philosophy. At VytronUS, patient safety is always our first priority and improved efficacy is our mission. We look forward to making our products available to doctors and their patients in the near future.
Type
Private
HQ
Sunnyvale, US
Founded
2006
VytronUS was founded in 2006 and is headquartered in Sunnyvale, US
Report incorrect company information

Key People/Management at VytronUS

John Pavlidis

John Pavlidis

CEO
Patrick Phillips PhD

Patrick Phillips PhD

Sr. VP Engineering and Manufacturing
Paul Chan

Paul Chan

VP Finance
Mike Horzewski

Mike Horzewski

COO
Dave White

Dave White

VP Manufacturing
Danielo Piazza

Danielo Piazza

VP Software Engineering
Show more

VytronUS Office Locations

VytronUS has an office in Sunnyvale
Sunnyvale, US (HQ)
658 N Pastoria Ave
Show all (1)
Report incorrect company information

VytronUS Financials and Metrics

Summary Metrics

Founding Date

2006

Total Funding

$133 m

Latest funding size

$49 m

Time since last funding

2 years ago

Investors

VytronUS's latest funding round in July 2016 was reported to be $49 m. In total, VytronUS has raised $133 m
Show all financial metrics
Report incorrect company information